The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis
NCT00874133 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2013-12-06
Summary
Diabetes affects 5.8% of the adult population in Israel (1). Gastroparesis is a syndrome characterized by delayed gastric emptying in the absence of mechanical obstruction of the stomach.Treatment with acupuncture has been described as effective in improvement of symptoms in patients with gastroparesis in a number of patient series. However, this treatment approach has not been tested by means of a controlled randomized clinical study, and neither has the connection between improvement of symptoms and the anatomical-physiological effect of the treatment, if ever, assessed.This study will test the efficacy of motilium (20 mg thrice daily) as compared to acupuncture treatment on the following subjective and objective parameters of 30 patients with diabetic gastroparesis and impaired glucose control:
1. To compare the degree of GCSI scores improvement before and after treatment with motilium or acupuncture using a validated questionnaire.
2. To determine the effect of treatment with motilium or acupuncture on gastric emptying rate.
3. To determine the effect of treatment with motilium or acupuncture on glycemic control.
4. To compare the quality of life before and after treatment with motilium or acupuncture using the Short Form-36 (SF-36).
Conditions
- Diabetic Gastroparesis
Interventions
- PROCEDURE
-
Acupuncture
Acupuncture treatment for 12 weeks.
- DRUG
-
Motilium
20 mg motilium thrice daily
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Ram Dickman, MD · RMC
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
More Related Trials
-
Ghrelin Repeated Dose Study
NCT01833078 ·Status: COMPLETED ·Phase: PHASE2
-
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated with HD
NCT04301726 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis
NCT05167760 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
NCT02016885 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS
NCT04391361 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
NCT03880266 ·Status: COMPLETED ·Phase: PHASE2
-
Nicergoline Use in Dysphagia Patients
NCT05551182 ·Status: COMPLETED ·Phase: PHASE3
-
Enteral Glutamine in Neurologically-injured Patients
NCT00204971 ·Status: COMPLETED ·Phase: PHASE4
-
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
NCT00950196 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Oral Treatment MTR-601 in Cervical Dystonia
NCT06830642 ·Status: SUSPENDED ·Phase: PHASE2
-
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
NCT00904436 ·Status: COMPLETED ·Phase: NA
-
Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects
NCT02212821 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
NCT06173531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
NCT03759678 ·Status: TERMINATED ·Phase: PHASE2
-
Buspirone for Functional Dysphagia
NCT02674412 ·Status: COMPLETED ·Phase: NA
-
Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia
NCT01085903 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
NCT01885936 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
NCT01035671 ·Status: COMPLETED ·Phase: PHASE2
-
Ghrelin Plus Strength Training in Frail Elderly Study
NCT01898611 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults
NCT02656160 ·Status: COMPLETED ·Phase: PHASE2
-
Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects
NCT02088398 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)
NCT04875949 ·Status: COMPLETED ·Phase: NA
-
Different Doses of Naronapride vs. Placebo in Gastroparesis
NCT05621811 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects
NCT01644240 ·Status: TERMINATED ·Phase: PHASE1